KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+5.64%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$544M
AUM Growth
+$544M
(+3.6%)
Cap. Flow
-$3.68M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
160
New
23
Increased
38
Reduced
25
Closed
2
Top Buys
| 1 |
DuPont de Nemours
DD
|
$4.27M |
| 2 |
Salesforce
CRM
|
$4.19M |
| 3 |
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
|
$2.66M |
| 4 |
AGN
Allergan plc
AGN
|
$2.2M |
| 5 |
Schlumberger
SLB
|
$1.59M |
Top Sells
| 1 |
Alkermes
ALKS
|
$6.96M |
| 2 |
Merck
MRK
|
$4.78M |
| 3 |
Lockheed Martin
LMT
|
$4.5M |
| 4 |
D.R. Horton
DHI
|
$2.46M |
| 5 |
PayPal
PYPL
|
$1.69M |
Sector Composition
| 1 | Financials | 21.26% |
| 2 | Healthcare | 17.86% |
| 3 | Technology | 17.65% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
26
DELISTED
Allergan plc
AGN
| $8.53M | 1.57% |
52,124
+13,425
| +35% | +$2.2M |
|
27
Goldman Sachs
GS
$226B
| $8.44M | 1.55% |
33,112
+355
| +1% | +$90.4K |
|
|
28
Schlumberger
SLB
$55B
| $7.71M | 1.42% |
114,458
+23,575
| +26% | +$1.59M |
|
|
29
Merck
MRK
$210B
| $7.64M | 1.4% |
135,710
-85,011
| -39% | -$4.78M |
|
30
Enovis
ENOV
$1.77B
| $7.04M | 1.3% |
177,750
| – | – |
|
31
Alphabet (Google) Class C
GOOG
$2.58T
| $6.84M | 1.26% |
6,537
| – | – |
|
32
JPMorgan Chase
JPM
$829B
| $6.48M | 1.19% |
60,610
| – | – |
|
33
Cisco
CSCO
$274B
| $6.18M | 1.14% |
161,251
+130
| +0.1% | +$4.98K |
|
34
Applied Materials
AMAT
$128B
| $6.04M | 1.11% |
118,105
-715
| -0.6% | -$36.5K |
|
35
Edwards Lifesciences
EW
$47.8B
| $5.9M | 1.08% |
52,300
+5,100
| +11% | +$575K |
|
|
36
DuPont de Nemours
DD
$32.2B
| $5.86M | 1.08% |
82,325
+60,000
| +269% | +$4.27M |
|
|
37
Salesforce
CRM
$245B
| $4.19M | 0.77% |
+41,000
| New | +$4.19M |
|
38
Procter & Gamble
PG
$368B
| $3.6M | 0.66% |
39,155
-150
| -0.4% | -$13.8K |
|
39
Vertex Pharmaceuticals
VRTX
$100B
| $3.04M | 0.56% |
20,302
-405
| -2% | -$60.7K |
|
|
DLPH
40
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $2.66M | 0.49% |
+50,757
| New | +$2.66M |
|
41
AbbVie
ABBV
$372B
| $2.55M | 0.47% |
26,345
-250
| -0.9% | -$24.2K |
|
42
3M
MMM
$82.8B
| $2.54M | 0.47% |
10,792
| – | – |
|
43
Gilead Sciences
GILD
$140B
| $2.12M | 0.39% |
29,605
| – | – |
|
44
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.82B
| $1.93M | 0.36% |
1,475
+80
| +6% | +$105K |
|
|
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.84M | 0.34% |
27,574
| – | – |
|
46
Albemarle
ALB
$9.99B
| $1.65M | 0.3% |
12,917
-1,041
| -7% | -$133K |
|
47
Verizon
VZ
$186B
| $1.62M | 0.3% |
30,675
+6,750
| +28% | +$357K |
|
48
Exxon Mobil
XOM
$487B
| $1.61M | 0.3% |
19,268
+350
| +2% | +$29.3K |
|
|
CYS.PRB
49
DELISTED
CYS Investments, Inc.
CYS.PRB
| $1.56M | 0.29% |
63,050
+2,000
| +3% | +$49.6K |
|
50
GE Aerospace
GE
$292B
| $1.33M | 0.24% |
76,298
| – | – |
|